These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2931004)

  • 1. Destructive interactions between murine macrophages, tumor cells, and antibodies of the IgG2a isotype.
    Johnson WJ; Steplewski Z; Koprowski H; Adams DO
    Adv Exp Med Biol; 1985; 184():75-80. PubMed ID: 2931004
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation and characterization of anti-monosialoganglioside monoclonal antibody 19-9 class-switch variants.
    Steplewski Z; Spira G; Blaszczyk M; Lubeck MD; Radbruch A; Illges H; Herlyn D; Rajewsky K; Scharff M
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8653-7. PubMed ID: 2934735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothesis: macrophages as effector cells for human tumor destruction mediated by monoclonal antibody.
    Steplewski Z; Herlyn D; Maul G; Koprowski H
    Hybridoma; 1983; 2(1):1-5. PubMed ID: 6678794
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation.
    Johnson WJ; Steplewski Z; Matthews TJ; Hamilton TA; Koprowski H; Adams DO
    J Immunol; 1986 Jun; 136(12):4704-13. PubMed ID: 3711663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of tumor growth inhibition.
    Steplewski Z; Herlyn D; Lubeck M; Kimoto Y; Herlyn M; Koprowski H
    Hybridoma; 1986 Jul; 5 Suppl 1():S59-64. PubMed ID: 3744386
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis.
    Adams DO; Hall T; Steplewski Z; Koprowski H
    Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3506-10. PubMed ID: 6587365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous exposure to FcγR and FcαR on monocytes and macrophages enhances antitumor activity in vivo.
    Li B; Xu L; Tao F; Xie K; Wu Z; Li Y; Li J; Chen K; Pi C; Mendelsohn A; Larrick JW; Gu H; Fang J
    Oncotarget; 2017 Jun; 8(24):39356-39366. PubMed ID: 28454118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
    Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
    MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell lysis and tumor growth inhibition by the isotype variants of MAb BR55-2 directed against Y oligosaccharide.
    Steplewski Z; Lubeck MD; Scholz D; Loibner H; McDonald Smith J; Koprowski H
    In Vivo; 1991; 5(2):79-83. PubMed ID: 1768791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells.
    Rüegg SJ; Jungi TW
    Immunology; 1988 Mar; 63(3):513-20. PubMed ID: 2965100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells.
    Steplewski Z; Lubeck MD; Koprowski H
    Science; 1983 Aug; 221(4613):865-7. PubMed ID: 6879183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a mutated IgA2 antibody of the m(1) allotype against the epidermal growth factor receptor for the recruitment of monocytes and macrophages.
    Lohse S; Brunke C; Derer S; Peipp M; Boross P; Kellner C; Beyer T; Dechant M; van der Winkel JG; Leusen JH; Valerius T
    J Biol Chem; 2012 Jul; 287(30):25139-50. PubMed ID: 22679018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal IgM rheumatoid factors derived from arthritic MRL/Mp-lpr/lpr mice.
    Theofilopoulos AN; Balderas RS; Hang L; Dixon FJ
    J Exp Med; 1983 Sep; 158(3):901-19. PubMed ID: 6224885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo destruction of canine lymphoma mediated by murine monoclonal antibodies.
    Steplewski Z; Rosales C; Jeglum KA; McDonald-Smith J
    In Vivo; 1990; 4(4):231-4. PubMed ID: 2103365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine monoclonal IgG antibodies: differences in their IgG isotypes can affect the antibody effector activity when using human cells.
    Lobo PI; Patel HC
    Immunol Cell Biol; 1997 Jun; 75(3):267-74. PubMed ID: 9243292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody bipolar bridging: isotype-dependent signals given to guinea pig alveolar macrophages by anti-MHC alloantibodies.
    Benichou G; Voisin GA
    Cell Immunol; 1987 May; 106(2):304-17. PubMed ID: 2952286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagocytosis by mouse peritoneal macrophages plated on monoclonal antibody-coated immune complex-substrates: effects of complexes of different IgG subclasses on Fc receptor functions.
    Sung SS
    J Immunol; 1985 Sep; 135(3):1981-6. PubMed ID: 4020136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
    Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Vijh S; Johnson S; Bonvini E; Koenig S
    Cancer Res; 2007 Sep; 67(18):8882-90. PubMed ID: 17875730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of a second epitope of the murine Fc receptor for aggregated IgG.
    Puré E; Witmer MD; Lum JB; Mellman I; Unkeless JC
    J Immunol; 1987 Dec; 139(12):4152-8. PubMed ID: 2447161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
    Masui H; Moroyama T; Mendelsohn J
    Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.